Results for the substance baloxavir marboxil

Baloxavir marboxil is an antiviral used in the treatment of acute uncomplicated influenza in patients aged 12 years and older. It works by inhibiting the cap-dependent endonuclease, an enzyme essential for influenza virus replication, thereby reducing the duration and severity of symptoms.

Baloxavir is administered orally as a single dose, preferably within 48 hours of symptom onset. It is effective against influenza A and B strains, including those resistant to other antivirals such as oseltamivir.

Common side effects include diarrhea, nausea, and headache. In rare cases, severe allergic reactions such as skin rashes or difficulty breathing may occur. It is important for patients to follow their doctor's instructions and not discontinue treatment prematurely.

Baloxavir marboxil is a modern and effective therapeutic option for managing influenza, contributing to reduced complications and faster recovery for patients.